ISSN: 2578-4803
Authors: H Fai Poon* , Jun Yuan , Wayne WenYan Xu , Henry XiaoYu Yu and Lothar Yuling Jiang
The commercial success and expiring patents of biological therapeutics has made biosimilars become attractive to pharmaceutical companies. However, the cost of manufacturing biosimilars has remained a challenge for many companies. Therefore, the ability to mimic the biologically active molecule at the lowest possible cost via cell culture has become the key of successful biosimilar development. Hence, we review current cell culture technologies that are relevant to biosimilar development. The cell line, culture media and bioprocess technology platforms discussed in current review lays a good scientific foundation for the technological competitiveness of biosimilar companies.
Keywords: Biosimilar; Robust; Cell; Biopharmaceutical
Chat with us on WhatsApp